Global Clinical Decision Support Systems (CDSS) Market - 1-3 USERS:2021

Global Clinical Decision Support Systems (CDSS) Market - 1-3 USERS:2021

Global Clinical Decision Support Systems (CDSS) Market: Analysis and Forecast, 2021-2030

4 600,00 €

Détails

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2030 - Start Value : $2.09 Billion in 2021 - Forecast Value : $3.74 Billion by 2030 - CAGR % : 0.07%
Description :
Market Report Coverage - Global CDSS Market

Market Segmentation

• Product Type (Integrated and Standalone)
• CDSS Type (Conventional and Advanced)
• Application (Preventive Care, Diagnostics, Follow-Up Management, Others (Planning, Implementation, etc.)
• End User (Hospitals and Clinics, Ambulatory Surgical Centers, Other End Users (Nursing Homes, Elderly Care Centers, etc.)
• User Interactivity (Active CDSS and Passive CDSS)
• Model (Knowledge-Based and Non-Knowledge Based)
• Delivery Mode (On-Premise CDSS and Cloud-Based CDSS)

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, Rest-of-Asia-Pacific (RoAPAC)
• Rest-of-the-World

Growth Drivers

• Growing Emphasis on Reducing Medical Errors and Hospital Readmission Rates to Reduce Healthcare Costs
• Rise in the Number of Chronic Diseases
• Technological Advancements in the Field of Information Technology
• Shortage of Healthcare Workforce to Drive Demand for CDSS
• Partnerships between CDSS Vendors and Cloud-Based Service Providers

Market Challenges

• Reluctance of Clinicians to use CDSS Systems due to Computer Illiteracy
• Lack of Interoperability among CDSS and EHR
• Data Security and Privacy Concerns

Market Opportunities

• Integration of CDSS with Blockchain
• Collaborations with Precision Medicine Providers
• Business Expansion in the Emerging Markets
• Product Differentiation

Key Companies Profiled

Allscripts Healthcare Solutions, Inc., Cerner Corporation, Change Healthcare, General Electric Company, International Business Machines Corporation, McKesson Corporation, RELX Group, Wolters Kluwer N.V., Epic Systems Corporation, Hearst Corporation, Inferscience, Inc., Medical Information Technology, Inc. (MEDITECH), Oncology Analytics, Inc., Persivia Inc., and VisualDx. In addition, the report also provides snapshots for three players, namely, CureMD Healthcare, RAMPmedical Henisaja GmbH, and The Medical Algorithms Company Limited.

Key Questions Answered in this Report:

• How has COVID-19 impacted the adoption of CDSS as well as the market dynamics influencing it?
• What are the key regulations governing the CDSS market in key regions?
• What are the technological developments which are expected to have the maximum influence on the global CDSS market?
• Who are the leading players to hold significant dominance on the global CDSS market currently?
• What are the key business models being followed by the key players in the market?
• What are some of the major factors which are expected to influence the growth in adoption of CDSS across the globe?
• What are the key strategies incorporated by leading players in the global CDSS market landscape?
• What is the current revenue contribution for the different types of CDSS, and what are the expected modifications in the forecast period?
• Which countries contribute to the major share of the current demand, and which ones hold significant scope for growth during the next 10 years?

Key USPs of the Report

Following are some of the key contents of the report:

• Industry Analysis
o Ecosystem Analysis
o Evidence-Based Analysis
o Entry Barriers to Adoption/Implementation
o Regulatory Framework
o Patent Landscape

• Impact of COVID-19
This section of the report encompasses the following:
o Key Trends
o Scenario Competitive Analysis (Pre-COVID, During-COVID, and Post-COVID-19)
o Effect on Competitive Landscape and Product Demand
o Regional Impact
o Future Perspective and Recommendations

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
• Company revenue share analysis for 2019

Expert Quote

“The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes.”

Scope of the Global CDSS Market

The purpose of the study is to enable the reader to gain a holistic view of the global CDSS market by each of the segments mentioned above.

The research report constitutes an in-depth study of the global CDSS market, including a thorough analysis of revenues generated from the use of CDSS in professional healthcare settings. Based on the product launches, approvals, and ongoing strategic collaborations, as well as business expansions, the market size and potential for the forecast period of 2021-2030 have been estimated.
Countries Covered :
North America
U.S.
Canada
Europe
Germany
Italy
France
Spain
U.K.
Rest-of-Europe
Asia-Pacific
China
India
South Korea
Australia
Japan
Rest-of-Asia-Pacific
Rest-of-World
Keywords :
Clinical Decision Support Systems, Clinical Decision Support Systems Market, Clinical Decision Support Systems Industry, Clinical Decision Support Systems Report, Clinical Decision Support Systems Market Forecasts, Clinical Decision Support Systems Market Trends, Clinical Decision Support Systems Market Products, Clinical Decision Support Systems Market Applications, Clinical Decision Support Systems Market Companies, Clinical Decision Support Systems Market Analysis, Clinical Decision Support Systems Industry Analysis, What is Clinical Decision Support Systems, Clinical Decision Support Systems Definition, CDSS, CDSS Market, CDSS Industry, CDSS Report, CDSS Market Forecasts, CDSS Market Trends, CDSS Market Products, CDSS Market Applications, CDSS Market Companies, CDSS Market Analysis, CDSS Industry Analysis, What is CDSS, CDSS Definition, Robotic Surgery Clinical Decision Support Systems Market, Machine Learning Clinical Decision Support Systems Market, Natural Language, Processing Clinical Decision Support Systems Market, Big Data Analytics Clinical Decision Support Systems Market, Artificial Intelligence Clinical Decision Support Systems Market, Integrated Clinical Decision Support Systems Market, Standalone Clinical Decision Support Systems Market, Active CDSS Market, Passive CDSS Market, Conventional Clinical Decision Support Systems Market, Advanced Clinical Decision Support Systems Market, On-Premise CDSS Market, Cloud-Based CDSS Market, Knowledge-Based CDSS Market, Non-Knowledge-Based CDSS Market, Preventive Care Clinical Decision Support Systems Market, Diagnostics Clinical Decision Support Systems Market, Follow-Up Management Clinical Decision Support Systems Market, Hospitals and Clinics Clinical Decision Support Systems Market, Ambulatory Surgical Centers Clinical Decision Support Systems Market, North America Clinical Decision Support Systems Market, Europe Clinical Decision Support Systems Market, Asia-Pacific Clinical Decision Support Systems Market
Press Release :
The global clinical decision support system CDSS market is projected to reach $3.74 billion by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 6.70% between 2021 and 2030.

The CDSS is a type of software that aids in clinical decision-making by matching the characteristics of a patient with a knowledge base. This forms the basis of recommendations presented to a clinician. Modern CDSS are interoperable and are used at point-of-care. The medical professional can use the CDSS recommendations and combine their knowledge with the recommendations provided.

The clinical decision support systems of the future are expected to be developed to leverage data to make observations that are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate.

The comprehensive study of the global CDSS market by BIS Research extensively covers the following:

• Market numbers on CDSS type, product type, user interactivity, applications, delivery mode, model, and end-users, along with regional cross-segmentation by end users.
• More than 68 key offerings present in the market
• Impact on CDSS market due to COVID-19 and potential recovery scenarios
• Patent filing landscape
• Market share analysis for global CDSS market
• Detailed global and regional market share analysis, including the scrutiny of 15 countries.
Who should buy this report?
• CDSS vendors (software solutions and platforms) to gain a holistic view of the market potential of various solutions and the developing economies for business expansions
• New entrants looking to venture into the CDSS market to get insights into the different applications, technologies, and models which are expected to witness increased adoption in the future.

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segment analysis, and evidence-based analysis.

BIS Research study indicates that the growing emphasis on reducing medical errors as well as hospital readmission rates, rise in the number of chronic diseases, technological advancements in the field of information technology, and partnerships between CDSS vendors and cloud service providers are fueling the growth of the global CDSS market.

The study highlights the various emerging opportunities, such as integration of CDSS with blockchain, collaborations with precision medicine providers, business expansion in emerging markets with high demand for CDSS, which can be leveraged by players operating in the market.

To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include CDSS type, product type, user interactivity, applications, delivery mode, model, end-users, and region.

The application segment of the global market includes analysis of different types of CDSS applications such as preventive care, diagnostics, follow-up management, and other applications.

To emphasize the impact of COVID-19 on the global CDSS market, Swati Sood, Lead Analyst – BIS Research, states, "In the pre-COVID-19 scenario, the adoption of CDSS was mainly driven by the growing need to reduce medical errors. However, the COVID-19 pandemic has resulted in a significant increase in teleconsultations, remote monitoring, and AI integration in healthcare applications for expedited results. This ongoing transition is expected to enable a future of interoperability driven by AI and machine learning at the core. Moreover, the COVID-19 pandemic is anticipated to have a long-term impact on the market transition. CDSS adoption in emerging countries has been accelerated as a result of it.”

Key insights are drawn from in-depth interviews with the key opinion leaders of leading companies, market participants, and vendors. The key players profiled in the report include Allscripts Healthcare Solutions, Inc., Cerner Corporation, Change Healthcare, General Electric Company, International Business Machines Corporation, McKesson Corporation, RELX Group, Wolters Kluwer N.V., Epic Systems Corporation, Hearst Corporation, Inferscience, Inc., Medical Information Technology, Inc. (MEDITECH), Oncology Analytics, Inc., Persivia Inc., and VisualDx. In addition, the report also provides snapshots for three players, namely, CureMD Healthcare, RAMPmedical Henisaja GmbH, and The Medical Algorithms Company Limited.

How can market intelligence on CDSS add value to an organization’s decision-making process?

• Aid in product development
• Aid in understanding the regulatory scenario of the market in different regions
• Aid in understanding the patent trend of the market
• Help in targeting a segment for launching a new product
• Support in diversifying the portfolio
• Aid in understanding technology penetration in different healthcare applications
• Aid in understanding the end-user requirement
• Support in analyzing the market opportunities
• Provide insights on the key companies in the market

Insightful Questions Covered to Enable Companies to take Strategic Decisions

• How has COVID-19 impacted the adoption of CDSS as well as the market dynamics influencing it?
• What are the key regulations governing the CDSS market in key regions?
• What are the technological developments which are expected to have the maximum influence on the global CDSS market?
• Who are the leading players to hold significant dominance on the global CDSS market currently?
• What are the key business models being followed by the key players in the market?
• What are some of the major factors expected to influence the growth in the adoption of CDSS across the globe?
• What are the key strategies incorporated by leading players in the global CDSS market landscape?
• What is the current revenue contribution for the different types of CDSS, and what are the expected modifications in the forecast period?
• Which countries contribute to the major share of the current demand, and which ones hold significant scope for growth during the next 10 years?
Companies Mentioned :
Allscripts Healthcare Solutions, Inc.
Cerner Corporation
Change Healthcare
Epic Systems Corporation
General Electric Company
Hearst Corporation
Inferscience, Inc.
International Business Machines Corporation
McKesson Corporation
Medical Information Technology, Inc. (MEDITECH)
Oncology Analytics, Inc.
Persivia Inc.
RELX Group
VisualDx
Wolters Kluwer N.V.
CureMD Healthcare
RAMPmedical Henisaja GmbH
The Medical Algorithms Company Limited
Press Release :
The global clinical decision support system CDSS market is projected to reach $3.74 billion by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 6.70% between 2021 and 2030.

The CDSS is a type of software that aids in clinical decision-making by matching the characteristics of a patient with a knowledge base. This forms the basis of recommendations presented to a clinician. Modern CDSS are interoperable and are used at point-of-care. The medical professional can use the CDSS recommendations and combine their knowledge with the recommendations provided.

The clinical decision support systems of the future are expected to be developed to leverage data to make observations that are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate.

The comprehensive study of the global CDSS market by BIS Research extensively covers the following:

• Market numbers on CDSS type, product type, user interactivity, applications, delivery mode, model, and end-users, along with regional cross-segmentation by end users.
• More than 68 key offerings present in the market
• Impact on CDSS market due to COVID-19 and potential recovery scenarios
• Patent filing landscape
• Market share analysis for global CDSS market
• Detailed global and regional market share analysis, including the scrutiny of 15 countries.
Who should buy this report?
• CDSS vendors (software solutions and platforms) to gain a holistic view of the market potential of various solutions and the developing economies for business expansions
• New entrants looking to venture into the CDSS market to get insights into the different applications, technologies, and models which are expected to witness increased adoption in the future.

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segment analysis, and evidence-based analysis.

BIS Research study indicates that the growing emphasis on reducing medical errors as well as hospital readmission rates, rise in the number of chronic diseases, technological advancements in the field of information technology, and partnerships between CDSS vendors and cloud service providers are fueling the growth of the global CDSS market.

The study highlights the various emerging opportunities, such as integration of CDSS with blockchain, collaborations with precision medicine providers, business expansion in emerging markets with high demand for CDSS, which can be leveraged by players operating in the market.

To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include CDSS type, product type, user interactivity, applications, delivery mode, model, end-users, and region.

The application segment of the global market includes analysis of different types of CDSS applications such as preventive care, diagnostics, follow-up management, and other applications.

To emphasize the impact of COVID-19 on the global CDSS market, Swati Sood, Lead Analyst – BIS Research, states, "In the pre-COVID-19 scenario, the adoption of CDSS was mainly driven by the growing need to reduce medical errors. However, the COVID-19 pandemic has resulted in a significant increase in teleconsultations, remote monitoring, and AI integration in healthcare applications for expedited results. This ongoing transition is expected to enable a future of interoperability driven by AI and machine learning at the core. Moreover, the COVID-19 pandemic is anticipated to have a long-term impact on the market transition. CDSS adoption in emerging countries has been accelerated as a result of it.”

Key insights are drawn from in-depth interviews with the key opinion leaders of leading companies, market participants, and vendors. The key players profiled in the report include Allscripts Healthcare Solutions, Inc., Cerner Corporation, Change Healthcare, General Electric Company, International Business Machines Corporation, McKesson Corporation, RELX Group, Wolters Kluwer N.V., Epic Systems Corporation, Hearst Corporation, Inferscience, Inc., Medical Information Technology, Inc. (MEDITECH), Oncology Analytics, Inc., Persivia Inc., and VisualDx. In addition, the report also provides snapshots for three players, namely, CureMD Healthcare, RAMPmedical Henisaja GmbH, and The Medical Algorithms Company Limited.

How can market intelligence on CDSS add value to an organization’s decision-making process?

• Aid in product development
• Aid in understanding the regulatory scenario of the market in different regions
• Aid in understanding the patent trend of the market
• Help in targeting a segment for launching a new product
• Support in diversifying the portfolio
• Aid in understanding technology penetration in different healthcare applications
• Aid in understanding the end-user requirement
• Support in analyzing the market opportunities
• Provide insights on the key companies in the market

Insightful Questions Covered to Enable Companies to take Strategic Decisions

• How has COVID-19 impacted the adoption of CDSS as well as the market dynamics influencing it?
• What are the key regulations governing the CDSS market in key regions?
• What are the technological developments which are expected to have the maximum influence on the global CDSS market?
• Who are the leading players to hold significant dominance on the global CDSS market currently?
• What are the key business models being followed by the key players in the market?
• What are some of the major factors expected to influence the growth in the adoption of CDSS across the globe?
• What are the key strategies incorporated by leading players in the global CDSS market landscape?
• What is the current revenue contribution for the different types of CDSS, and what are the expected modifications in the forecast period?
• Which countries contribute to the major share of the current demand, and which ones hold significant scope for growth during the next 10 years?
Headline :
Global CDSS Market to Reach $3.74 Billion by 2030
Table of Contents :
Executive Summary
1 Product Definition
2 Scope of Research
2.1 Scope of the Study
2.2 Inclusion and Exclusion Criteria
2.3 Key Questions Answered in the Report
3 Research Methodology
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Data Sources Categorization
3.4 Selection Criteria for Company Profiles
3.5 Brief Overview of the Market Estimation Process
3.6 Data Validation
3.7 Assumptions and Limitations
4 Impact of COVID-19 on the Global Clinical Decision Support Systems Market
4.1 Key Trends
4.2 Scenario Comparative Analysis
4.3 Effect on Competitive Landscape and Product Demand
4.4 Regional Impact
4.5 Future Perspective and Recommendations
5 Industry Analysis
5.1 Industry Ecosystem
5.2 Evidence-Based Analysis
5.3 Entry Barriers to Adoption of CDSS
5.4 Legal and Regulatory Framework
5.4.1 Regulatory Framework in the U.S.
5.4.2 Regulatory Framework in the European Union
5.5 Patent Landscape
5.5.1 Insights About Awaited Technological Advancements
5.5.1.1 The Transition from CDS Version 1.0 to Newer Versions
5.5.1.2 Robotic Surgery
5.5.1.3 Machine Learning
5.5.1.4 Natural Language Processing (NLP)
5.5.1.5 Big Data Analytics
5.5.1.6 Artificial Intelligence
5.5.2 Patent Filing Trend
5.5.2.1 Patent Analysis by Country
5.5.2.2 Patent Analysis by Year
6 Competitive Landscape
6.1 Market Share Analysis
6.2 Key Developments and Strategies
6.2.1 Partnerships, Collaborations, and Agreements
6.2.2 New Offerings and Regulatory Approvals
6.2.3 Mergers and Acquisitions
6.2.4 Funding Activities
6.3 Business Model Analysis
7 Global Clinical Decision Support Systems Market, 2019-2030
7.1 Assumptions and Limitations
7.2 Key Findings and Opportunity Assessment
7.3 Global Clinical Decision Support Systems (CDSS) Market Size & Forecast, 2019-2030
7.4 Market Dynamics
7.4.1 Market Growth-Promoting Factors
7.4.1.1 Growing Emphasis on Reducing Medical Errors and Hospital Readmission Rates to Reduce Healthcare Costs
7.4.1.2 The Rise in the Number of Chronic Diseases
7.4.1.3 Technological Advancements in the Field of Information Technology
7.4.1.4 Shortage of Healthcare Workforce to Drive Demand for CDSS
7.4.1.5 Partnerships between CDSS Vendors and Cloud-Based Service Providers
7.4.2 Market Growth Inhibiting Factors
7.4.2.1 The Reluctance of Clinicians to use CDSS Systems due to Computer Illiteracy
7.4.2.2 Lack of Interoperability among CDSS and EHR
7.4.2.3 Data Security and Privacy Concerns
7.4.3 Market Growth Opportunities
7.4.3.1 Integration of CDSS with Blockchain
7.4.3.2 Collaborations with Precision Medicine Providers
7.4.3.3 Business Expansion in the Emerging Markets
7.4.3.4 Product Differentiation
7.4.4 Impact Analysis
8 Global Clinical Decision Support Systems Market (by Product Type)
8.1 Key Findings and Opportunity Assessment
8.2 Integrated
8.3 Standalone
9 Global Clinical Decision Support Systems Market (by User Interactivity)
9.1 Key Findings and Opportunity Assessment
9.2 Active CDSS
9.3 Passive CDSS
10 Global Clinical Decision Support Systems Market (by CDSS Type)
10.1 Key Findings and Opportunity Assessment
10.2 Conventional
10.3 Advanced
11 Global Clinical Decision Support Systems Market, (by Delivery Mode)
11.1 Key Findings and Opportunity Assessment
11.2 On-Premise CDSS
11.3 Cloud-Based CDSS
12 Global Clinical Decision Support Systems Market (by Model)
12.1 Key Findings and Opportunity Assessment
12.2 Knowledge-Based CDSS
12.3 Non-Knowledge-Based CDSS
13 Global Clinical Decision Support Systems Market (by Application)
13.1 Key Findings and Opportunity Assessment
13.2 Preventive Care
13.3 Diagnostics
13.4 Follow-Up Management
13.5 Other Applications
14 Global Clinical Decision Support Systems Market (by End User)
14.1 Key Findings and Opportunity Assessment
14.2 Hospitals and Clinics
14.3 Ambulatory Surgical Centers (ASCs)
14.4 Other End Users (Elderly Care Homes, Nursing Homes, etc.)
15 Global Clinical Decision Support Systems Market (by Region)
15.1 North America Clinical Decision Support Systems Market
15.1.1 Opportunity Assessment
15.1.2 Market Size and Forecast, by End Users
15.1.3 Market Share and Forecast, by Country
15.1.3.1 U.S.
15.1.3.2 Canada
15.2 Europe Clinical Decision Support Systems Market
15.2.1 Opportunity Assessment
15.2.2 Market Size and Forecast, by End User
15.2.3 Market Share and Forecast (by Country)
15.2.3.1 Germany
15.2.3.2 U.K.
15.2.3.3 France
15.2.3.4 Italy
15.2.3.5 Spain
15.2.3.6 Rest-of-Europe
15.3 Asia-Pacific Clinical Decision Support Systems (CDSS) Market
15.3.1 Opportunity Assessment
15.3.2 Market Size and Forecast, by End User
15.3.3 Market Share and Forecast (by Country)
15.3.3.1 China
15.3.3.2 Japan
15.3.3.3 India
15.3.3.4 Australia
15.3.3.5 South Korea
15.3.3.6 Rest-of-Asia-Pacific
15.4 Rest-of-the-World Clinical Decision Support Systems Market
15.4.1 Opportunity Assessment
15.4.2 Market Size and Forecast, by End User
15.4.3 Market Share and Forecast, by Country
15.4.3.1 Brazil
15.4.3.2 Russia
15.4.3.3 U.A.E.
15.4.3.4 Rest-of-RoW
16 Company Profiles
16.1 Allscripts Healthcare Solutions, Inc.
16.1.1 Company Overview
16.1.2 Role of Allscripts Healthcare Solutions, Inc. in the Global Clinical Decision Support Systems Market
16.1.3 Recent Developments
16.1.4 Financials
16.1.5 SWOT Analysis: Allscripts Healthcare Solutions, Inc.
16.2 Cerner Corporation
16.2.1 Company Overview
16.2.2 Role of Cerner Corporation in the Global Clinical Decision Support Systems Market
16.2.3 Recent Developments
16.2.4 Financials
16.2.5 SWOT Analysis: Cerner Corporation
16.3 Change Healthcare
16.3.1 Company Overview
16.3.2 Role of Change Healthcare in the Global Clinical Decision Support Systems Market
16.3.3 Recent Developments
16.3.4 Financials
16.3.5 SWOT Analysis: Change Healthcare
16.4 Epic Systems Corporation
16.4.1 Company Overview
16.4.2 Role of Epic Systems Corporation in the Global Clinical Decision Support Systems Market
16.4.3 Recent Developments
16.4.4 SWOT Analysis: Epic Systems Corporation
16.5 General Electric Company
16.5.1 Company Overview
16.5.2 Role of General Electric Company in the Global Clinical Decision Support Systems Market
16.5.3 Recent Developments
16.5.4 Financials
16.5.5 SWOT Analysis: General Electric Company
16.6 Hearst Corporation
16.6.1 Company Overview
16.6.2 Role of Hearst Corporation in the Global Clinical Decision Support Systems Market
16.6.3 Recent Developments
16.6.4 SWOT Analysis: Hearst Corporation
16.7 Inferscience, Inc.
16.7.1 Company Overview
16.7.2 Role of Inferscience, Inc. in the Global Clinical Decision Support Systems Market
16.7.3 Recent Developments
16.7.4 SWOT Analysis: Inferscience, Inc.
16.8 International Business Machines Corporation
16.8.1 Company Overview
16.8.2 Role of International Business Machines Corporation in the Global Clinical Decision Support Systems Market
16.8.3 Recent Developments
16.8.4 Financials
16.8.5 SWOT Analysis: International Business Machines Corporation
16.9 McKesson Corporation
16.9.1 Company Overview
16.9.2 Role of McKesson Corporation in the Global Clinical Decision Support Systems Market
16.9.3 Recent Developments
16.9.4 Financials
16.9.5 SWOT Analysis: McKesson Corporation
16.1 Medical Information Technology, Inc. (MEDITECH)
16.10.1 Company Overview
16.10.2 Role of Medical Information Technology, Inc. in the Global Clinical Decision Support Systems Market
16.10.3 Recent Developments
16.10.4 SWOT Analysis: Medical Information Technology, Inc.
16.11 Oncology Analytics, Inc.
16.11.1 Company Overview
16.11.2 Role of Oncology Analytics, Inc. in the Global Clinical Decision Support Systems Market
16.11.3 Recent Developments
16.11.4 SWOT Analysis: Oncology Analytics, Inc.
16.12 Persivia Inc.
16.12.1 Company Overview
16.12.2 Role of Persivia Inc. in the Global Clinical Decision Support Systems Market
16.12.3 Recent Developments
16.12.4 SWOT Analysis: Persivia Inc.
16.13 RELX Group
16.13.1 Company Overview
16.13.2 Role of RELX Group in the Global Clinical Decision Support Systems Market
16.13.3 Recent Developments
16.13.4 Financials
16.13.5 SWOT Analysis: RELX Group
16.14 VisualDx
16.14.1 Company Overview
16.14.2 Role of VisualDx in the Global Clinical Decision Support Systems Market
16.14.3 Recent Developments
16.14.4 SWOT Analysis: VisualDx
16.15 Wolters Kluwer N.V.
16.15.1 Company Overview
16.15.2 Role of Wolters Kluwer N.V. in the Global Clinical Decision Support Systems Market
16.15.3 Recent Developments
16.15.4 Financials
16.15.5 SWOT Analysis: Wolters Kluwer N.V.
16.16 Company Snapshots
16.16.1 CureMD Healthcare
16.16.2 RAMPmedical Henisaja GmbH
16.16.3 The Medical Algorithms Company Limited
List of Tables
Table 1: Global CDSS Market: Key Barriers to Implementation
Table 2: Global CDSS Market: Key Developments, January 2016-December 2020
Table 3: COVID-19 Recovery Scenario Impact
Table 4.1: Regional Impact of COVID-19
Table 5.1: CDSS Adoption: Entry Barriers
Table 5.2: Regulatory Scenario Across the World
Table 5.3: IMDRF Classification: SaMD Categories
Table 5.4: FDA CDS Software Categorization
Table 5.5: Top Five CPCs for the Patents Filed During January 2017- December 2020
Table 5.6: Global Clinical Decision Support Systems Market: Patent Analysis (by Country), January 2017-December 2020
Table 7.1: Country-wise Analysis of Adverse Events (2016)
Table 7.2: The Number of Hospital Readmissions and the Cost Associated with them
Table 7.3: Prevalence of Chronic Diseases in the U.S and the Cost Incurred to Treat the Disease
Table 9.1: Active CDSS Systems: Advantages and Disadvantages
Table 9.2: Active CDSS: Commercially Available Products
Table 9.3: Passive CDSS Systems: Advantages and Disadvantages
Table 9.4: Passive CDSS: Commercially Available Products
Table 13.1: Global Clinical Decision Support Systems Market: Key Application Areas
Table 13.2: Drug-Allergy/Drug-Drug Interaction Alerts: Advantages and Disadvantages
Table 13.3: Clinical Reminders: Advantages and Disadvantages
Table 13.4: CDSS Dosing Support: Key Questions Answered
Table 13.5: Advantages and Disadvantages of Dosing Support
List of Figures
Figure 1: CDSS: Current Stage of Adoption and Future Potential
Figure 2: Global CDSS Market Dynamics Impact Analysis
Figure 3: Potential COVID-19 Recovery Scenarios
Figure 2.1: Global CDSS Market Segmentation
Figure 3.1: Global CDSS Market: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Total Number of CDSS Company Profiles
Figure 3.5: Assumptions and Limitations
Figure 4.1: Global CDSS Market Impact Analysis (COVID-19): Key Trends
Figure 4.2: Global CDSS Market: COVID-19 Impact on CDSS Adoption
Figure 4.3: Global CDSS Market Key Developments and Strategies Share (by Category), January 2020-December 2020
Figure 4.4: COVID-19 Trend (Daily Cases), December 31, 2019-December 14, 2020
Figure 4.5: COVID-19 Trend (Daily Deaths), December 31, 2019-December 14, 2020
Figure 4.6: Potential COVID-19 Recovery Scenarios
Figure 5.1: Global Clinical Decision Support Systems Market Industry Ecosystem
Figure 5.2: CDSS: Evidence of Effectiveness (Cardiovascular Disease Prevention)
Figure 5.3: CDSS: Evidence of Impact (Cardiovascular Disease Prevention)
Figure 5.4: Global Clinical Decision Support Systems Market: Patent Analysis (by Year), January 2017-December 2020
Figure 6.1: Global CDSS Market: Company Revenue Share Analysis, 2019
Figure 6.2: Share of Key Developments and Strategies in the Global Clinical Decision Support Systems Market (by Category), January 2016-December 2020
Figure 6.3: Key Developments in the Global Clinical Decision Support Systems Market (by Year), January 2016-December 2020
Figure 6.4: Global Clinical Decision Support Systems Market – Key Partnerships, Collaborations, and Agreements, January 2016-December 2020
Figure 6.5: Global Clinical Decision Support Systems Market – Key New Offerings and Regulatory Approvals, January 2016-December 2020
Figure 6.6: Global Clinical Decision Support Systems Market – Key Mergers and Acquisitions, January 2016-December 2020
Figure 6.7: Global Clinical Decision Support Systems Market – Key Funding Activities, January 2016-December 2020
Figure 7.1: Global CDSS Market Incremental Growth Opportunity Analysis, 2019-2030
Figure 7.2: Global CDSS Market Size and Growth Potential, $Billion, 2019-2030
Figure 7.3: Percentage of Hospital Readmissions
Figure 7.4: Global CDSS Market Dynamics Impact Analysis
Figure 8.1: Global CDSS Market, (by Product Type)
Figure 8.2: Global CDSS Market Incremental Revenue Opportunity (by Product Type), $Million, 2019-2030
Figure 8.3: Global Integrated CDSS Market, $Million, 2019-2030
Figure 8.4: Global Standalone CDSS Market, $Million, 2019-2030
Figure 9.1: Global CDSS Market, (by User Interactivity)
Figure 9.2: CDSS Knowledge Cycle
Figure 9.3: Global CDSS Market Incremental Revenue Opportunity (by User Interactivity), $Million, 2019-2030
Figure 9.4: Global Active CDSS Market, $Million, 2019-2030
Figure 9.5: Global Passive CDSS Market, $Million, 2019-2030
Figure 10.1: Global CDSS Market, (by CDSS Type)
Figure 10.2: Global CDSS Market Incremental Revenue Opportunity (by CDSS Type), $Million, 2019-2030
Figure 10.3: Global CDSS Market (Conventional), $Million, 2019-2030
Figure 10.4: Global CDSS Market (Advanced), $Million, 2019-2030
Figure 11.1: Global CDSS Market, (by Delivery Mode)
Figure 11.2: Global CDSS Market Incremental Revenue Opportunity (by Delivery Mode), $Million, 2019-2030
Figure 11.3: Global CDSS Market (On-Premise CDSS), $Million, 2019-2030
Figure 11.4: Global CDSS Market (Cloud-Based CDSS), $Million, 2019-2030
Figure 11.5: Cloud-Based CDSS: SaaS Architectural Design
Figure 12.1: Global CDSS Market, (by Model)
Figure 12.2: Global CDSS Market Incremental Revenue Opportunity (by Model), $Million, 2019-2030
Figure 12.3: Knowledge-Based CDSS Components
Figure 12.4: Global CDSS Market (Knowledge-Based CDSS), $Million, 2019-2030
Figure 12.5: Knowledge-Based CDSS: Key Interactions
Figure 12.6: Global CDSS Market (Non-Knowledge-Based CDSS), $Million, 2019-2030
Figure 12.7: Non-Knowledge-Based CDSS: Key Interactions
Figure 13.1: Global CDSS Market, (by Application)
Figure 13.2: Global CDSS Market Incremental Revenue Opportunity (by Application), $Million, 2019-2030
Figure 13.3: Global CDSS Market (Preventive Care), $Million, 2019-2030
Figure 13.4: Global CDSS Market (Diagnostics), $Million, 2019-2030
Figure 13.5: Global CDSS Market (Follow-Up Management), $Million, 2019-2030
Figure 13.6: Global CDSS Market: Role of Clinical Reminders
Figure 13.7: Global CDSS Market (by Other Applications)
Figure 13.8: Global CDSS Market (Other Applications), $Million, 2019-2030
Figure 14.1: Global CDSS Market (by End User)
Figure 14.2: Global CDSS Market Incremental Revenue Opportunity (by End User), $Million, 2019-2030
Figure 14.3: Global CDSS Market (Hospitals and Clinics), $Million, 2019-2030
Figure 14.4: Global CDSS Market (Ambulatory Surgical Centers), $Million, 2019-2030
Figure 14.5: Global CDSS Market (Other End Users), $Million, 2019-2030
Figure 15.1: Global CDSS Market (by Region), 2019 and 2030
Figure 15.2: Global CDSS Market (by Region), $Million, 2019-2030
Figure 15.3: North America CDSS Market Incremental Revenue Opportunity (by Country), $Million, 2019-2030
Figure 15.4: North America CDSS Market (by End Users), $Million, 2019-2030
Figure 15.5: North America CDSS Market Share Analysis (by Country), 2019 and 2030
Figure 15.6: U.S. CDSS Market, $Million, 2019-2030
Figure 15.7: U.S. Government Stimulus Package, 2020
Figure 15.8: Canada CDSS Market, $Million, 2019-2030
Figure 15.9: Europe CDSS Market Incremental Revenue Opportunity (by Country), $Million, 2019-2030
Figure 15.10: Europe CDSS Market (by End User), $Million, 2019-2030
Figure 15.11: Europe CDSS Market Share Analysis (by Country), 2019 and 2030
Figure 15.12: Germany CDSS Market, $Million, 2019-2030
Figure 15.13: U.K. CDSS Market, $Million, 2019-2030
Figure 15.14: France CDSS Market, $Million, 2019-2030
Figure 15.15: Italy CDSS Market, $Million, 2019-2030
Figure 15.16: Spain CDSS Market, $Million, 2019-2030
Figure 15.17: Rest-of-Europe CDSS Market, $Million, 2019-2030
Figure 15.18: Asia-Pacific CDSS Market Incremental Revenue Opportunity (by Country), $Million, 2019-2030
Figure 15.19: Asia-Pacific CDSS Market (by End Users), $Million, 2019-2030
Figure 15.20: Asia-Pacific CDSS Market Share Analysis (by Country), 2019 and 2030
Figure 15.21: China CDSS Market, $Million, 2019-2030
Figure 15.22: Japan CDSS Market, $Million, 2019-2030
Figure 15.23: India CDSS Market, $Million, 2019-2030
Figure 15.24: Australia CDSS Market, $Million, 2019-2030
Figure 15.25: South Korea CDSS Market, $Million, 2019-2030
Figure 15.26: Rest-of-Asia-Pacific CDSS Market, $Million, 2019-2030
Figure 15.27: Rest-of-the-World CDSS Market Incremental Revenue Opportunity (by Country), $Million, 2019-2030
Figure 15.28: Rest-of-the-World CDSS Market (by End Users), $Million, 2019-2030
Figure 15.29: Rest-of-the-World CDSS Market Share Analysis (by Country), 2019 and 2030
Figure 15.30: Brazil CDSS Market, $Million, 2019-2030
Figure 15.31: Russia CDSS Market, $Million, 2019-2030
Figure 15.32: U.A.E. CDSS Market, $Million, 2019-2030
Figure 15.33: Rest-of-RoW CDSS Market, $Million, 2019-2030
Figure 16.1: Allscripts Healthcare Solutions, Inc.: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.2: Allscripts Healthcare Solutions, Inc.: Overall Financials, 2017-2019
Figure 16.3: Allscripts Healthcare Solutions, Inc.: Revenue (by Segment), 2017-2019
Figure 16.4: Allscripts Healthcare Solutions, Inc.: Revenue (by Region), 2017-2019
Figure 16.5: SWOT Analysis: Allscripts Healthcare Solutions, Inc.
Figure 16.6: Cerner Corporation: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.7: Cerner Corporation: Overall Financials, 2017-2019
Figure 16.8: Cerner Corporation: Revenue (by Segment), 2017-2019
Figure 16.9: Cerner Corporation: Revenue (by Region), 2017-2019
Figure 16.10: SWOT Analysis: Cerner Corporation
Figure 16.11: Change Healthcare: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.12: Change Healthcare: Overall Financials, 2017-2019
Figure 16.13: Change Healthcare: Revenue (by Segment), 2017-2019
Figure 16.14: SWOT Analysis: Change Healthcare
Figure 16.15: Epic Systems Corporation: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.16: SWOT Analysis: Epic Systems Corporation
Figure 16.17: General Electric Company: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.18: General Electric Company: Overall Financials, 2017-2019
Figure 16.19: General Electric Company: Revenue (by Segment), 2017-2019
Figure 16.20: General Electric Company: Revenue (by Region), 2017-2019
Figure 16.21: SWOT Analysis: General Electric Company
Figure 16.22: Hearst: Subsidiaries Operating in the Global Clinical Decision Support Systems Market
Figure 16.23: SWOT Analysis: Hearst Corporation
Figure 16.24: Inferscience, Inc.: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.25: SWOT Analysis: Inferscience, Inc.
Figure 16.26: International Business Machines Corporation: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.27: International Business Machines Corporation: Overall Financials, 2017-2019
Figure 16.28: International Business Machines Corporation: Revenue (by Segment), 2017-2019
Figure 16.29: International Business Machines Corporation: Revenue (by Region), 2017-2019
Figure 16.30: SWOT Analysis: International Business Machines Corporation
Figure 16.31: McKesson Corporation: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.32: McKesson Corporation: Overall Financials, 2017-2019
Figure 16.33: McKesson Corporation: Revenue (by Segment), 2017-2019
Figure 16.34: McKesson Corporation: Revenue (by Region), 2017-2019
Figure 16.35: SWOT Analysis: McKesson Corporation
Figure 16.36: Medical Information Technology, Inc.: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.37: SWOT Analysis: Medical Information Technology, Inc.
Figure 16.38: Oncology Analytics, Inc.: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.39: SWOT Analysis: Oncology Analytics, Inc.
Figure 16.40: Persivia Inc.: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.41: SWOT Analysis: Persivia Inc.
Figure 16.42: RELX Group: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.43: RELX Group: Overall Financials, 2017-2019
Figure 16.44: RELX Group: Revenue (by Segment), 2017-2019
Figure 16.45: RELX Group: Revenue (by Region), 2017-2019
Figure 16.46: SWOT Analysis: RELX Group
Figure 16.47: VisualDx: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.48: SWOT Analysis: VisualDx
Figure 16.49: Wolters Kluwer N.V.: Product Offerings for the Global Clinical Decision Support Systems Market
Figure 16.50: Wolters Kluwer N.V.: Overall Financials, 2017-2019
Figure 16.51: Wolters Kluwer N.V.: Revenue (by Segment), 2017-2019
Figure 16.52: Wolters Kluwer N.V.: Revenue (by Region), 2017-2019
Figure 16.53: SWOT Analysis: Wolters Kluwer N.V.

Informations supplémentaires

Auteur BIS Research INC.
Edité par BISRESEARCH
Type de document Rapport
Nombre de pages 252
Mot-clé Global Clinical Decision Support Systems Market